Filing Details

Accession Number:
0000904454-11-000020
Form Type:
5
Zero Holdings:
No
Publication Time:
2011-02-10 18:16:18
Reporting Period:
2010-12-31
Filing Date:
2011-02-10
Accepted Time:
2011-02-10 18:16:18
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1279695 Universal Biosensors Inc UBI Surgical & Medical Instruments & Apparatus (3841) 980424072
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
200406 Johnson & Johnson One Johnson &Amp; Johnson Plaza
New Brunswick NJ 08901
No No Yes No
924020 Johnson & Johnson Development Corp Et Al One Johnson &Amp; Johnson Plaza
New Brunswick NJ 08901
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2010-07-29 1,222 $1.36 18,230,507 No 4 S Indirect By Johnson & Johnson Development Corporation
Common Stock Disposition 2010-07-30 7,240 $1.33 18,223,267 No 4 S Indirect By Johnson & Johnson Development Corporation
Common Stock Disposition 2010-08-02 344 $1.34 18,222,923 No 4 S Indirect By Johnson & Johnson Development Corporation
Common Stock Disposition 2010-08-03 1,088 $1.34 18,221,835 No 4 S Indirect By Johnson & Johnson Development Corporation
Common Stock Disposition 2010-08-04 6,425 $1.29 18,215,410 No 4 S Indirect By Johnson & Johnson Development Corporation
Common Stock Disposition 2010-08-05 7,111 $1.28 18,208,299 No 4 S Indirect By Johnson & Johnson Development Corporation
Common Stock Disposition 2010-08-06 1,269 $1.32 18,207,030 No 4 S Indirect By Johnson & Johnson Development Corporation
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect By Johnson & Johnson Development Corporation
No 4 S Indirect By Johnson & Johnson Development Corporation
No 4 S Indirect By Johnson & Johnson Development Corporation
No 4 S Indirect By Johnson & Johnson Development Corporation
No 4 S Indirect By Johnson & Johnson Development Corporation
No 4 S Indirect By Johnson & Johnson Development Corporation
No 4 S Indirect By Johnson & Johnson Development Corporation
Footnotes
  1. The securities reported as being indirectly beneficially owned by the Reporting Person are directly beneficially owned by Johnson & Johnson Development Corporation, a wholly-owed subsidiary of the Reporting Person.